Quick links
Government sites
Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 

تاريخ جدول الأعمال مقررات اللجنة
12-11-2015 Agenda12.11.2015  
11-11-2015 Agenda11.11.2015  
22-10-2015 Agenda22.10.2015 Decisions22.10.2015
21-10-2015 Agenda21.10.2015 Decisions21.10.2015
20-10-2015 Agenda20.10.2015 Decisions20.10.2015
19-10-2015 Agenda19.10.2015 Decisions19.10.2015
8-10-2015 Agenda8.10.2015 Decisions8.10.2015
7-10-2015 Agenda7.10.2015 Decisions7.10.2015
30-9-2015 Agenda30.9.2015 Decisions30.9.2015
29-9-2015 Agenda29.9.2015 Decisions29.9.2015
16-9-2015 Agenda16.9.2015 Decisions16.9.2015
15-9-2015 Agenda15.9.2015 Decisions15.9.2015
2-9-2015 Agenda2.9.2015 Decisions2.9.2015
1-9-2015 Agenda1.9.2015 Decisions1.9.2015
20-8-2015 Agenda20.8.2015 Decisions20.8.2015
19-8-2015 Agenda19.8.2015 Decisions19.8.2015
13-8-2015 Agenda13.8.2015 Decisions13.8.2015
12-8-2015 Agenda12.8.2015 Decisions12.8.2015
6-8-2015 Agenda6.8.2015 Decisions6.8.2015
5-8-2015 Agenda5.8.2015 Decisions5.8.2015
29-7-2015 Agenda29.7.2015 Decisions29.7.2015
28-7-2015 Agenda28.7.2015 Decisions28.7.2015
15-7-2015 Agenda15.7.2015 Decisions15.7.2015
14-7-2015 Agenda14.7.2015 Decisions14.7.2015
8-7-2015 Agenda8.7.2015 Decisions8.7.2015
7-7-2015 Agenda7.7.2015 Decisions7.7.2015
25-6-2015 Agenda25.6.2015 Decisions25.6.2015
24-6-2015 Agenda24.6.2015 Decisions24.6.2015
5-6-2015 Agenda5.6.2015 Decisions5.6.2015
4-6-2015 Agenda4.6.2015 Decisions4.6.2015
2-6-2015 Agenda2.6.2015 Decisions2.6.2015
1-6-2015 Agenda1.6.2015 Decisions1.6.2015
28-5-2015 Agenda28.5.2015 Decisions28.5.2015
27-5-2015 Agenda27.5.2015 Decisions27.5.2015
14-5-2015 Agenda14.5.2015 Decisions14.5.2015
13-5-2015 Agenda13.5.2015 Decisions13.5.2015
5-5-2015 Agenda5.5.2015 Decisions5.5.2015
4-5-2015 Agenda4.5.2015 Decisions4.5.2015
23-4-2015 Agenda23.4.2015 Decisions23.4.2015
22-4-2015 Agenda22.4.2015 Decisions22.4.2015
21-4-2015 Agenda21.4.2015 Decisions21.4.2015
20-4-2015 Agenda20.4.2015 Decisions20.4.2015
16-4-2015 Agenda16.4.2015 Decisions16.4.2015
15-4-2015 Agenda15.4.2015 Decisions15.4.2015
19-3-2015 Agenda19.3.2015 Decisions19.3.2015
18-3-2015 Agenda18.3.2015 Decisions18.3.2015
12-3-2015 Agenda12.3.2015 Decisions12.3.2015
11-3-2015 Agenda11.3.2015 Decisions11.3.2015
6-3-2015 Agenda6.3.2015 Decisions6.3.2015
5-3-2015 Agenda5.3.2015 Decisions5.3.2015
20-2-2015 Agenda20.2.2015 Decisions20.2.2015
19-2-2015 Agenda19.2.2015 Decisions19.2.2015
18-2-2015 Agenda18.2.2015 Decisions18.2.2015
17-2-2015 Agenda17.2.2015 Decisions17.2.2015
12-2-2015 Agenda12.2.2015 Decisions12.2.2015
11-2-2015 Agenda11.2.2015 Decisions11.2.2015
17-1-2015 Agenda17.1.2015 Decisions17.1.2015
16-1-2015 Agenda16.1.2015 Decisions16.1.2015
13-1-2015 Agenda13.1.2015 Decisions13.1.2015
12-1-2015 Agenda12.1.2015 Decisions12.1.2015
7-1-2015 Agenda7.1.2015 Decisions7.1.2015
5-1-2015 Agenda5.1.2015 Decisions5.1.2015
30-12-2014 Agenda30.12.2014 Decisions30.12.2014
29-12-2014 Agenda29.12.2014 Decisions29.12.2014
18-12-2014 Agenda18.12.2014 Decisions18.12.2014
17-12-2014 Agenda17.12.2014 Decisions17.12.2014
3-12-2014 Agenda3.12.2014 Decisions3.12.2014
2-12-2014 Agenda2.12.2014 Decisions2.12.2014
20-11-2014 Agenda20.11.2014 Decisions20.11.2014
19-11-2014 Agenda19.11.2014 Decisions19.11.2014
13-11-2014 Agenda13.11.2014 Decisions13.11.2014
12-11-2014 Agenda12.11.2014 Decisions12.11.2014
5-11-2014 Agenda5.11.2014 Decisions6.11.2014
4-11-2014 Agenda4.11.2014 Decisions5.11.2014
14-10-2014 Agenda14.10.2014 Decisions14.10.2014
13-10-20104 Agenda13.10.2014 Decisions13.10.2014
11-10-2014 Agenda11.10.2014 Decisions11.10.2014
10-10-2014 Agenda10.10.2014 Decisions10.10.2014
3-10-2014 Agenda3.10.2014 Decisions3.10.2014
2-10-2014 Agenda2.10.2014 Decisions2.10.2014
30-9-2014 Agenda30.9.2014 Decisions30.9.2014
29-9-2014 Agenda29.9.2014 Decisions29.9.2014
18-9-2014 Agenda18.9.2014 Decisions18.9.2014
17-9-2014 Agenda17.9.2014 Decisions17.9.2014
5-9-2014 Agenda5.9.2014 Decisions5.9.2014
4-9-2014 Agenda4.9.2014 Decisions4.9.2014
27-8-2014 Agenda27.8.2014 Decisions27.8.2014
26-8-2014 Agenda26.8.2014 Decisions26.8.2014
20-8-2014 Agenda20.8.2014 Decisions20.8.2014
19-8-2014 Agenda19.8.2014 Decisions19.8.2014
13-8-2014 Agenda13.8.2014 Decisions13.8.2014
12-8-2014 Agenda12.8.2014 Decisions12.8.2014
24-7-2014 Agenda24.7.2014 Decisions24.7.2014
23-7-2014 Agenda23.7.2014 Decisions23.7.2014
16-7-2014 Agenda16.7.2014 Decisions16.7.2014
15-7-2014 Agenda15.7.2014 Decisions15.7.2014
10-7-2014 Agenda10.7.2014 Decisions10.7.2014
9-7-2014 Agenda9.7.2014 Decisions9.7.2014
25-6-2014 Agenda25.6.2014 Decisions25.6.2014
23-6-2014 Agenda23.6.2014 Decisions23.6.2014
16-6-2014 Agenda16.6.2014 Decisions16.6.2014
9-6-2014 Agenda9.6.2014 Decisions9.6.2014
31-5-2014 Agenda31.5.2014 Decisions31.5.2014
30-5-2014 Agenda30.5.2014 Decisions30.5.2014
21-5-2014 Agenda21.5.2014 Decisions21.5.2014
20-5-2014 Agenda20.5.2014 Decisions20.5.2014
14-5-2014 Agenda14.5.2014 Decisions14.5.2014
13-5-2014 Agenda13.5.2014 Decisions13.5.2014
25-4-2014 Agenda25.4.2014 Decisions25.4.2014
24-4-2014 Agenda24.4.2014 Decisions24.4.2014
23-4-2014 Agenda23.4.2014 Decisions23.4.2014
22-4-2014 Agenda22.4.2014 Decisions22.4.2014
8-4-2014 Agenda8.4.2014 Decisions8.4.2014
7-4-2014 Agenda7.4.2014 Decisions7.4.2014
11-3-2014 Agenda11.3.2014 Decisions11.3.2014
10-3-2014 Agenda10.3.2014 Decisions10.3.2014
8-3-2014 Agenda8.3.2014 Decisions8.3.2014
7-3-2014 Agenda7.3.2014 Decisions7.3.2014
6-3-2014 Agenda6.3.2014 Decisions6.3.2014
5-3-2014 Agenda5.3.2014 Decisions5.3.2014
26-2-2014 Agenda26.2.2014 Decisions26.2.2014
25-2-2014 Agenda25.2.2014 Decisions25.2.2014
12-2-2014 Agenda12.2.2014 Decisions12.2.2014
11-2-2014 Agenda11.2.2014 Decisions11.2.2014
18-1-2014 Agenda18.1.2014 Decisions18.1.2014
17-1-2014 Agenda17.1.2014 Decisions17.1.2014
16-1-2014 Agenda16.1.2014 Decisions16.1.2014
15-1-2014 Agenda15.1.2014 Decisions15.1.2014
3-1-2014 Agenda3.1.2014 Decisions3.1.2014
2-1-2014 Agenda2.1.2014 Decisions2.1.2014
    ...
    13
ATC brand_name B/G Ingredients Dosage Form Price
C05AX05 PILOCIN G Tribenoside - 5%, Lidocaine HCl - 2% Cream 271,456 L.L
B05D PERITONEAL DIALYSIS SOLUTION WITH 4 1/4% DEXTROSE G Sodium lactate - 0.392g%, Calcium chloride, 2H2O - 0.0257g%, Magnesium chloride, 6H2O - 0.0153g%, Sodium chloride - 0.567g%, Dextrose, H2O - 4.25g% Injectable solution 498,744 L.L
B05D PERITONEAL DIALYSIS SOLUTION WITH 1 1/2% DEXTROSE G Sodium lactate - 0.392g%, Calcium chloride, 2H2O - 0.0257g%, Magnesium chloride, 6H2O - 0.0153g%, Sodium chloride - 0.567g%, Dextrose, H2O - 1.5g% Injectable solution 490,807 L.L
J01CR05 PIPERACILINA/TAZOBACTAM SALA G Piperacillin (sodium) - 4g, Tazobactam (sodium) - 0.5g Injectable powder for solution 913,813 L.L
J01CR05 PIPERACILLIN/TAZOBACTAM PANPHARMA G Piperacillin (sodium) - 4g, Tazobactam (sodium) - 0.5g Injectable powder for solution 7,461,939 L.L
J01CR05 PIPERACILLIN/TAZOBACTAM SANDOZ G Piperacillin (sodium) - 4g, Tazobactam (sodium) - 0.5g Injectable powder for solution 913,813 L.L
J01CR05 PIPERACILLIN/TAZOBACTAM SANDOZ G Piperacillin (sodium) - 4g, Tazobactam (sodium) - 0.5g Injectable powder for solution 7,961,483 L.L
J01CR05 PIPERACILLIN/TAZOBACTAM STRAGEN G Piperacillin (sodium) - 4g, Tazobactam (sodium) - 0.5g Injectable powder for solution 897,687 L.L
J01CR05 PIPERACILLIN/TAZOBACTAM STRAGEN G Piperacillin (sodium) - 4g, Tazobactam (sodium) - 0.5g Injectable powder for solution 7,820,986 L.L
J01CR05 PIPERACILLINE/ TAZOBACTAM ARROW G Piperacillin (sodium) - 4g, Tazobactam (sodium) - 500mg Injectable powder for solution 7,378,682 L.L
J01CR05 PIPTAZ-ORBUCELL G Piperacillin (sodium) - 4g, Tazobactam (sodium) - 0.5g Injectable powder for solution 1,087,873 L.L
J01CR05 PRIZMA G Piperacillin (sodium) - 4g, Tazobactam (sodium) - 0.5g Injectable powder for solution 913,813 L.L
J07AL01 PNEUMOVAX 23 B Polysaccharides from each of 23 capsular types of Streptococcus pneumoniae - 25mcgx23serotypes/0.5ml Injectable solution 2,378,601 L.L
J07AL02 PREVENAR 13 B Polysaccharide for serotypes 1, 3, 4, 5 , 6A, 7F, 9V,14, 18C, 19A, 19F, 23F (2.2mcg)Polysaccharide for serotypes 6B (4.4mcg)Conjugated to CRM197 carrier protein and adsorbed on aluminium phosphate (0.125mg aluminium) - Injectable suspension 6,352,343 L.L
B05XA PEDITRACE B Sodium selenite 5H2O (anhydrous) - 6.66mcg/ml, Sodium fluoride - 126mcg/ml, Potassium iodide - 1.31mcg/ml, Zinc chloride - 521mcg/ml, Copper chloride - 53.7mcg/ml, Manganese chloride 4H2O - 3.6mcg/ml Injectable concentrated solution 4,749,139 L.L
J07AL02 PNEUMOSIL (10-VALENT) G Pneumococcal polysaccharide conjugate vaccine (adsorbed) - Injectable suspension 3,386,483 L.L
S02CA06 POLYDEXA G Dexamethasone sodium metasulfobenzoate - 1.000.000IU/100ml, Polymyxin B sulfate - 100mg/100ml, Neomycin sulfate - 650.000IU/100ml Drops solution 208,296 L.L
J07AL02 PREVENAR 20 B Pneumococcal polysaccharide for serotypes 1, 3, 4, 5 , 6A, 7F,8, 9V,10A, 11A, 12F, 14, 15B, 18C, 19A, 19F,22F, 23F, 33F (2.2mcg) Pneumococcal polysaccharide for serotypes 6B (4.4mcg)Conjugated to CRM197 carrier protein (approximately 51mcg) adsorbed on aluminium phosphate (0.125mg aluminium) - Injectable suspension 7,415,107 L.L
S02CA07 PAROTICIN G Fludrocortisone acetate - 1mg/ml, Polymyxin B (sulfate) - 10.000IU/ml, Lidocaine - 50mg/ml Drops solution 319,835 L.L
G04BX14 PRIXETIN 60 G Dapoxetine (hydrochloride) - 60mg Tablet, film coated 1,479,123 L.L
A02BD08 PYLERA B Bismuth subcitrate potassium - 140mg, Tetracycline HCl - 125mg, Metronidazole - 125mg Capsule 6,156,142 L.L
M01AB55 PANCLO B12 G Diclofenac sodium - 75mg, Betamethasone disodium phosphate - 2mg, Hydroxocobalamin sulphate - 10mg Injectable solution 1,158,392 L.L
J07BD52 PRIORIX B Rubella virus live attenuated - ?10³ CCID50, Mumps virus live attenuated - ?103.7 CCID50, Measles virus live attenuated - ?10³ CCID50 Injectable lyophilised powder for solution+diluent 1,142,266 L.L
J07BF03 POLIOMYELITIS VACCINE INACTIVATED B Poliomyelitis virus type 1 inactivated - 40D.U, Poliomyelitis virus type 2 inactivated - 8D.U, Poliomyelitis virus type 3 inactivated - 32D.U Injectable suspension 1,206,771 L.L
N01BB54 PRILA G Prilocaine - 2.5% w/w, Lidocaine - 2.5% w/w Cream 1,057,604 L.L
N01BB54 PRILA G Prilocaine - 2.5% w/w, Lidocaine - 2.5% w/w Cream 1,163,768 L.L
C10BA03 PRAVAFEN B Pravastatin sodium - 40mg, Fenofibrate - 160mg Capsule, hard 1,264,556 L.L
A03AX12 PHLOROGLUCINOL/TRIMETHYLPHLOROGLUCINOL ARROW G Phloroglucinol - 40mg/4ml, Trimethylphloroglucinol - 0.04mg/4ml Injectable solution 940,690 L.L
R06AA52 PULMONAL EXPECTORANT G Diphenhydramine HCl - 0.015g/5ml, Ammonium HCl - 0.1g/5ml Syrup 177,899 L.L
J07CA06 PENTAXIM B Poliomyelitis virus type 3 inactivated(Prefilled syringe) - 32D.U., Poliomyelitis virus type 2 inactivated(Prefilled syringe) - 8D.U., Poliomyelitis virus type 1 inactivated(Prefilled syringe) - 40D.U., Bordetella pertussis antigen (Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg, Tetanus toxoid (Prefilled syringe) - ?40IU, Diphtheria toxoid (Prefilled syringe) - ?30IU, H. Influenza type b polysaccharide(Vial) - 10mcg Injectable dry powder+suspension 2,558,676 L.L
    ...
    13
Sitemap
© Copyrights reserved to Ministry of Public Health 2026